Carlos N. Carillo's most recent trade in SAB Biotherapeutics Inc was a trade of 17,681 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 22, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics Inc | Carlos N. Carillo | SVP Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 17,681 | 17,681 | - | - | Employee Stock Option (right to buy) |